A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This crucial tumor inhibitor protein is frequently inactivated in several types of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research